Dr. Jin Sun L. Bitar, MD

Dr. Bitar practices at Cedars-Sinai Medical Care Foundation in Beverly Hills, California.

Dr. Bitar's NPI, 1477940161, was assigned on April 20, 2015. Dr. Bitar graduated from Sungkyunkwan university school of medicine in 2006. Dr. Bitar holds California license A150397.

Dr. Bitar's primary practice is Cedars-Sinai Medical Care Foundation, at 8501 Wilshire Blvd, Beverly Hills, CA 90211 in Los Angeles County. The practice phone is (310) 385-3200.

Dr. Bitar's primary practice is Cedars-Sinai Medical Care Foundation in Beverly Hills, California. Dr. Bitar is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. Bitar to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bitar practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Bitar's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Bitar is board certified in hematology by the American Board of Internal Medicine. Dr. Bitar is licensed in California.

Dmand AI lists breast cancer, chronic leukemia, colorectal cancer, lymphoma and prostate cancer among the conditions Dr. Bitar treats.

CMS data shows 400 Medicare services from Dr. Bitar across 6 procedure codes in 2024, for 142 Medicare patients. Medicare paid $33,194 for them.

CMS counts 142 Medicare patients who saw Dr. Bitar in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have cancer, and 68% have high cholesterol. 32% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bitar's median patient age at 67, with 94% women.

In 2024, Dr. Bitar wrote 327 Medicare Part D claims for 80 patients. 76% of them were for generic drugs. CMS names the drug for 201 of them, across 6 drugs with 11 or more claims each, at $598,516 in total drug cost. In 2023, CMS named 82 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Bitar for performance year 2024, reported as part of a group. Dr. Bitar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bitar as offering telehealth.

CMS Open Payments shows 235 general payments to Dr. Bitar from 45 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 66% of the total. Merck Sharp & Dohme Corporation paid the most, $2,393.

Dr. Bitar graduated from Sungkyunkwan university school of medicine in 2006.

Dr. Bitar is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.